Abstract
Some of the most important and interesting molecules in metazoan biology are glycoproteins. The importance of the carbohydrate component of these structures is often revealed by the disease phenotypes that manifest when the biosynthesis of particular glycoforms is disrupted. On the other hand, the presence of large amounts of carbohydrate can often hinder the structural and functional analysis of glycoproteins. There are often good reasons, therefore, for wanting to engineer and predefine the N-glycans present on glycoproteins, e.g., in order to characterize the functions of the glycans or facilitate their subsequent removal. Here, we describe in detail two distinct ways in which to usefully interfere with oligosaccharide processing, one involving the use of specific processing inhibitors, and the other the selection of cell lines mutated at gene loci that control oligosaccharide processing, using cytotoxic lectins. Both approaches have the capacity for controlled, radical alteration of oligosaccharide processing in eukaryotic cells used for heterologous protein expression, and have great utility in the structural analysis of glycoproteins.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Gagneux P, Varki A (1999) Evolutionary considerations in relating oligosaccharide diversity to biological function. Glycobiology 9:747–755
Julenius K, Molgaard A, Gupta R et al (2005) Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites. Glycobiology 15:153–164
Leahy DJ, Axel R, Hendrickson WA (1992) Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 Å resolution. Cell 68:1145–1162
Kornfeld R, Kornfeld S (1985) Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 54:631–644
Parodi AJ (2000) Protein glucosylation and its role in protein folding. Annu Rev Biochem 69:69–93
Schachter H (1991) The ‘yellow brick road’ to branched complex N-glycans. Glycobiology 1:453–461
Davis SJ, Puklavec MJ, Ashford DA et al (1993) Expression of soluble recombinant glycoproteins with predefined glycosylation: application to the crystallization of the T-cell glycoprotein CD2. Protein Eng 6:229–232
Davis SJ, Davies EA, Barclay AN et al (1995) Ligand binding by the immunoglobulin superfamily recognition molecule CD2 is glycosylation-independent. J Biol Chem 270:369–375
Butters TD, Sparks LM, Harlos K et al (1999) Effects of N-butyldeoxynojirimycin and the Lec3.2.8.1 mutant phenotype on N-glycan processing in Chinese hamster ovary cells: application to glycoprotein crystallization. Protein Sci 8:1696–1701
Chang VT, Crispin M, Aricescu AR et al (2007) Glycoprotein structural genomics: solving the glycosylation problem. Structure 15:267–273
Durocher Y, Perret S, Kamen A (2002) High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res 30: E9
Davie A, Greene A, Lullau E et al (2005) Optimisation and evaluation of a high-throughput mammalian protein expression system. Protein Expr Purif 42:111–21
Geisse S, Henke M (2005) Large-scale transient transfection of mammalian cells: a newly emerging attractive option for recombinant protein production. J Struct Funct Genomics 6:165–70
Aricescu AR, Assenberg R, Bill RM et al (2006) Eukaryotic expression: developments for structural proteomics. Acta Crystallogr D Biol Crystallogr 62:1114–1124
Reeves PJ, Callewaert N, Contreras R et al (2002) Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK 293S stable mammalian cell line. Proc Natl Acad Sci U S A 99:13419–13424
Aricescu AR, Siebold C, Choudhuri K et al (2007) Structure of a tyrosine phosphatase adhesive interaction reveals a spacer-clamp mechanism. Science 317:1217–1220
Crispin M, Chang VT, Harvey DJ et al (2009) A human embryonic kidney 293T cell line mutated at the Golgi α-mannosidase II locus. J Biol Chem 284:21684–21695
Jones EY, Davis SJ, Williams AF et al (1992) Crystal structure at 2.8 Å resolution of a soluble form of the cell adhesion molecule CD2. Nature 360:232–239
Bodian DL, Jones EY, Harlos K et al (1994) Crystal structure of the extracellular region of the human adhesion molecule CD2 at 2.5 Å resolution. Structure 2:755–766
Ikemizu S, Sparks LM, van der Merwe PA et al (1999) Crystal structure of the CD2-binding domain of CD58 (lymphocyte function-associated antigen 3) at 1.8 Å resolution. Proc Natl Acad Sci U S A 96:4289–4294
Evans EJ, Castro MA, O’Brien R et al (2006) Crystal structure and binding properties of the CD2 and CD244 (2B4)-binding protein, CD48. J Biol Chem 281:29309–29320
Ikemizu S, Glibert RJ, Fennelly JA et al (2000) Structure and dimerization of a soluble form of B7-1. Immunity 12:51–60
Yu C, Sonnen AF, George R et al (2011) Rigid-body ligand recognition drives cytotoxic T-lymphocyte antigen 4 (CTLA-4) receptor triggering. J Biol Chem 286:6685–6696
Bowden TA, Baruah K, Coles CH et al (2012) Chemical and structural analysis of an antibody folding intermediate trapped during glycan biosynthesis. J Am Chem Soc 134:17554–17563
Crispin M, Bowden TA, Coles CH et al (2009) Carbohydrate and domain architecture of an immature antibody glycoform exhibiting enhanced effector functions. J Mol Biol 387:1061–1066
Crispin M, Yu X, Bowden TA (2013) Crystal structure of sialylated IgG Fc: implications for the mechanism of intravenous immunoglobulin therapy. Proc Natl Acad Sci U S A 110:E3544–3546
Bowden TA, Crispin M, Graham SC et al (2009) Unusual molecular architecture of the machupo virus attachment glycoprotein. J Virol 83:8259–8265
Lyumkis D, Julien JP, de Val N et al (2013) Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. Science 342:1484–1490
Demaison C, Parsley K, Brouns G et al (2002) High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther 13:803–813
Aricescu AR, Lu W, Jones EY (2006) A time and cost efficient system for high level protein production in mammalian cells. Act Crystallogr D Biol Crystallogr 10:1243–1250
Grueninger-Leitch F, D’Arcy A, D’Arcy B et al (1996) Deglycosylation of proteins for crystallization using recombinant fusion protein glycosidases. Protein Sci 5:2617–2622
Olsnes S, Pihl A (1982) In: Cohen P, van Heyningen S (Eds). Molecular action of toxins and viruses. Elsevier, Amsterdam. pp. 51–105
Spooner RA, Lord JM (2012) How ricin and shiga toxin reach the cytosol of target cells: retrotranslocation from the endoplasmic reticulum. Curr Top Microbiol Immunol 357:19–40
Spooner RA, Watson PD, Marsden CJ et al (2004) Protein disulphide-isomerase reduces ricin to its A and B chains in the endoplasmic reticulum. Biochem J 383:285–293
Li S, Spooner RA, Allen SC et al (2010) Folding-competent and folding-defective forms of Ricin A chain have different fates following retrotranslocation from the endoplasmic reticulum. Mol Biol Cell 21:2543–2554
Spooner RA, Hart PJ, Cook JP et al (2008) Cytosolic chaperones influence the fate of a toxin dislocated from the endoplasmic reticulum. Proc Natl Acad Sci U S A 105:17408–17413
Pietroni P, Vasisht N, Cook JP et al (2013) The proteasome cap RPT5/Rpt5p subunit prevents aggregation of unfolded ricin A chain. Biochem J 453:435–445
Acknowledgements
This work was supported by the European Commission as SPINE (contract QLG2-CT-2002-00988) under the Integrated Programme “Quality of Life and Management of Living Resources,” the Wellcome Trust, Cancer Research UK, the Biotechnology and Biological Sciences Research Council, the Medical Research Council, and the Glycobiology Institute Endowment.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Chang, V.T., Spooner, R.A., Crispin, M., Davis, S.J. (2015). Glycan Remodeling with Processing Inhibitors and Lectin-Resistant Eukaryotic Cells. In: Castilho, A. (eds) Glyco-Engineering. Methods in Molecular Biology, vol 1321. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2760-9_21
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2760-9_21
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2759-3
Online ISBN: 978-1-4939-2760-9
eBook Packages: Springer Protocols